Celcuity Inc. (CELC) stock
CELCNasdaqServices-Medical LaboratoriesFiscal year ends December 31
$55.60−2.41 (-4.15%)
Close on Nov 18, 2026Market cap $2.72BP/E –Yield –
Celcuity shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Celcuity's shares outstanding was 55M at Jun 30, 2026. For fiscal 2025 it was 47M, up 18.5% from the year before. The highest annual figure on record is 47M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 47M | +18.5% |
| FY2024 | Dec 31, 2024 | 39M | +66.6% |
| FY2023 | Dec 31, 2023 | 24M | +53.6% |
| FY2022 | Dec 31, 2022 | 15M | +15.2% |
| FY2021 | Dec 31, 2021 | 13M | +30.3% |
| FY2020 | Dec 31, 2020 | 10M | +0.4% |
| FY2019 | Dec 31, 2019 | 10M | +1.0% |
| FY2018 | Dec 31, 2018 | 10M | +35.7% |
| FY2017 | Dec 31, 2017 | 7M | +18.2% |
| FY2016 | Dec 31, 2016 | 6M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 55M | +25.5% |
| Q1 FY2026 | Mar 31, 2026 | 54M | +26.5% |
| Q4 FY2025 | Dec 31, 2025 | 53M | +22.8% |
| Q3 FY2025 | Sep 30, 2025 | 48M | +11.2% |
| Q2 FY2025 | Jun 30, 2025 | 44M | +13.6% |
| Q1 FY2025 | Mar 31, 2025 | 43M | +28.1% |
| Q4 FY2024 | Dec 31, 2024 | 43M | +48.1% |
| Q3 FY2024 | Sep 30, 2024 | 43M | +93.5% |
| Q2 FY2024 | Jun 30, 2024 | 38M | +75.1% |
| Q1 FY2024 | Mar 31, 2024 | 34M | +55.0% |
| Q4 FY2023 | Dec 31, 2023 | 29M | +71.5% |
| Q3 FY2023 | Sep 30, 2023 | 22M | +48.1% |
| Q2 FY2023 | Jun 30, 2023 | 22M | +47.1% |
| Q1 FY2023 | Mar 31, 2023 | 22M | +45.3% |
| Q4 FY2022 | Dec 31, 2022 | 17M | +13.1% |
| Q3 FY2022 | Sep 30, 2022 | 15M | +0.4% |
| Q2 FY2022 | Jun 30, 2022 | 15M | +18.4% |
| Q1 FY2022 | Mar 31, 2022 | 15M | +34.7% |
| Q4 FY2021 | Dec 31, 2021 | 15M | +45.2% |
| Q3 FY2021 | Sep 30, 2021 | 15M | +44.8% |
| Q2 FY2021 | Jun 30, 2021 | 13M | +22.9% |
| Q1 FY2021 | Mar 31, 2021 | 11M | +8.0% |
| Q4 FY2020 | Dec 31, 2020 | 10M | +0.3% |
| Q3 FY2020 | Sep 30, 2020 | 10M | +0.3% |
| Q2 FY2020 | Jun 30, 2020 | 10M | +0.5% |
| Q1 FY2020 | Mar 31, 2020 | 10M | +0.5% |
| Q4 FY2019 | Dec 31, 2019 | 10M | +0.9% |
| Q3 FY2019 | Sep 30, 2019 | 10M | +1.1% |
| Q2 FY2019 | Jun 30, 2019 | 10M | +1.0% |
| Q1 FY2019 | Mar 31, 2019 | 10M | +1.0% |
| Q4 FY2018 | Dec 31, 2018 | 10M | +0.5% |
| Q3 FY2018 | Sep 30, 2018 | 10M | +47.9% |
| Q2 FY2018 | Jun 30, 2018 | 10M | +57.0% |
| Q1 FY2018 | Mar 31, 2018 | 10M | +56.8% |
| Q4 FY2017 | Dec 31, 2017 | 10M | +56.8% |
| Q3 FY2017 | Sep 30, 2017 | 7M | +6.3% |
| Q2 FY2017 | Jun 30, 2017 | 6M | – |
| Q1 FY2017 | Mar 31, 2017 | 6M | – |
| Q4 FY2016 | Dec 31, 2016 | 6M | – |
| Q3 FY2016 | Sep 30, 2016 | 6M | – |
See a number that looks wrong?